Published in:
01-04-2018 | Letter to Editor
Immunologist’s Perspectives on Assessment and Management of Lung Disease in CVID: a Survey of the Membership of the Clinical Immunology Society and the European Society for Immunodeficiencies
Authors:
Javeed Akhter, Cheryl A. Lefaiver, Christopher Scalchunes, Michael DiGirolamo, Klaus Warnatz
Published in:
Journal of Clinical Immunology
|
Issue 3/2018
Login to get access
Excerpt
Over 350 primary immunodeficiency diseases are currently recognized. Other than selective IgA deficiency, common variable immunodeficiency (CVID) is the most common primary immunodeficiency disease [
1]. The prevalence of CVID is estimated to be one in 25,000, but this is at best an educated guess. An International Consensus Document (ICON) [
2] has proposed a revised definition for CVID and compared it with the previously published criteria suggested by Ameratunga et al. [
3]. The usual practice is to use simpler criteria proposed by the European Society of Immune Deficiency Disorders (ESID) and Pan-American Group for Immunodeficiency (PAGID) [
4]. …